Monday, June 22, 2020

Aurobindo Pharma plans to launch 50-60 products in US in FY21

The company has received final approval for six ANDAs (abbreviated new
drug application) and launched four products in the fourth quarter of
last fiscal.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-plans-to-launch-50-60-products-in-us-in-fy21/articleshow/76509828.cms

No comments:

Post a Comment